Nasdaq:US$15.39 (+0.31) | HKEX:HK$24.28 (-0.46) | AIM:£2.32 (-0.04)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 27 Sep 2015

ESMO 2015: Phase II trial of fruquintinib in metastatic colorectal cancer

1 items
View PDF